English | Español

Amgen Inc.
Jamie Barrand | Feb 24, 2016

Romosozumab decreases spinal fracture risk in postmenopausal women, study indicates
Jamie Barrand | Feb 18, 2016

Anemia therapy study yields positive results
Jamie Barrand | Feb 9, 2016

Third trial of Repatha reveals positive results
Matt Smith | Jan 26, 2016

FDA to review application for Amgen's ABP 501 treatment
Jamie Barrand | Dec 27, 2015

Researchers unveil findings of acute lymphoblastic leukemia therapy trials
Jamie Barrand | Dec 18, 2015

Amgen reacquires rights to three GSK medications
Jamie Barrand | Dec 5, 2015

Amgen submits Marketing Authorization Application for ABP 501 to European Medicines Agency
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’